MedTrace Logo

A Single-center Observational Clinical Trial of Stereotactic Radiotherapy on Metastatic Spinal Tumors Using TomoTherapy

NCT05808998 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2023-04-12

No results posted yet for this study

Summary

A single-center observational clinical trial will be performed for metastatic spinal tumors by stereotactic radiotherapy using TomoTherapy. In this study, we will explore the local control rate (LCR), disease-free progression time (PFS), overall survival time (OS), and pain relief in patients with spinal metastasis, so as to provide a basis for developing relevant guidelines or consensus.

Conditions

  • Spinal Bone Metastases
  • Radiation Therapy

Interventions

RADIATION

Stereotactic body radiotherapy

Stereotactic body radiotherapy using TomoTherapy

Sponsors & Collaborators

  • Shanghai Zhongshan Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-01
Primary Completion
2025-04-01
Completion
2025-04-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05808998 on ClinicalTrials.gov